Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term safety study of brivaracetam adjunctive therapy in pediatric epilepsy
jRCT2041200093Active, not recruiting
- Sponsor
- UCB
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of brivaracetam in epilepsy, Focal Onset Epilepsy and focal-onset epileptic seizures, sponsored by UCB. Started Mar 2021; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsyfocal-onset epileptic seizures
Beyond the preview
Go deeper on jRCT2041200093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041200093.